Related Experiment Video
Updated: Jun 7, 2026
05:27
Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
Published on: October 6, 2023
Antivenin-related serum sickness
Chin-Yuan Huang1, Dong-Zong Hung, Wei-Kung Chen
1Emergency Department, China Medical University, Taichung, Taiwan, R.O.C.
Journal of the Chinese Medical Association : JCMA
|November 6, 2010
Summary
Serum sickness, a hypersensitivity reaction, can occur after antivenin treatment for snakebites. High doses of antivenin may increase the risk, as seen in a Taiwanese patient receiving 20 vials.
Area of Science:
- Immunology
- Toxicology
- Clinical Medicine
Background:
- Serum sickness is a type III hypersensitivity reaction caused by immune complex deposition.
- Antivenin therapy for snakebites involves foreign proteins, posing a risk for serum sickness.
- Serum sickness post-antivenin is common in the USA but less reported in Taiwan, possibly due to dosage differences.
Observation:
- A 59-year-old male developed serum sickness 10 days after receiving 20 vials of polyvalent antivenin for snakebite.
- Symptoms included fever, headaches, polyarthritis, and a diffused skin rash.
- The large antivenin dose was a potential contributing factor.
Findings:
- This case highlights a potential link between high-dose antivenin therapy and the development of serum sickness.
- The incidence of serum sickness may vary geographically due to differences in antivenin efficacy and administration protocols.
Implications:
- Physicians should consider the risk of serum sickness when administering large doses of antivenin.
- Awareness of this adverse reaction is crucial for prompt diagnosis and management in snakebite patients.
- Further research into antivenin dosage and serum sickness incidence in Taiwan is warranted.
Related Concept Videos
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...